Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Nazlı Seray Bostancı, Senem Büyüksungur, Nesrin Hasirci & Ayşen Tezcaner. (2022) Potential of pectin for biomedical applications: a comprehensive review. Journal of Biomaterials Science, Polymer Edition 33:14, pages 1866-1900.
Read now
Read now
Nivedita Gautam & Karthikeyan Kesavan. (2021) Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study. Current Eye Research 46:12, pages 1844-1852.
Read now
Read now
Pankaj Kumar Sharma & Meenakshi Kanwar Chauhan. (2021) Optimization and Characterization of Brimonidine Tartrate Nanoparticles-loaded In Situ Gel for the Treatment of Glaucoma. Current Eye Research 46:11, pages 1703-1716.
Read now
Read now
Hoda E. Teba, Islam A. Khalil & Heba M. El Sorogy. (2021) Novel cubosome based system for ocular delivery of acetazolamide. Drug Delivery 28:1, pages 2177-2186.
Read now
Read now
Viran Jayanetti, Sartaj Sandhu & Jed A Lusthaus. (2020) The Latest Drugs in Development That Reduce Intraocular Pressure in Ocular Hypertension and Glaucoma. Journal of Experimental Pharmacology 12, pages 539-548.
Read now
Read now
Lech Sedlak, Weronika Wojnar, Maria Zych & Dorota Wyględowska-Promieńska. (2020) Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film. Cutaneous and Ocular Toxicology 39:3, pages 260-268.
Read now
Read now
Lindsay Machen, Reza Razeghinejad & Jonathan S. Myers. (2020) Fixed-combination topical anti-hypertensive ophthalmic agents. Expert Opinion on Pharmacotherapy 21:10, pages 1269-1282.
Read now
Read now
Rohan K. Barse, Amol A. Tagalpallewar, Chandrakant R. Kokare, Jaya P. Sharma & Pankaj K. Sharma. (2018) Formulation and ex vivo–in vivo evaluation of pH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 32 factorial design. Drug Development and Industrial Pharmacy 44:5, pages 800-807.
Read now
Read now
Jed Asher Lusthaus & Ivan Goldberg. (2017) Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation. Expert Opinion on Drug Safety 16:9, pages 1071-1078.
Read now
Read now
Sourabh Sharma, Sameer Trikha, Shamira A Perera & Tin Aung. (2015) Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension. Clinical Ophthalmology 9, pages 2201-2207.
Read now
Read now
Toyoaki Tsumura, Keiji Yoshikawa, Tairo Kimura, Hirotaka Suzumura, Miwako Kawashima, Mami Nanno, Kiyotaka Ishijima & Ryuji Takeda. (2014) The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients. Clinical Ophthalmology 8, pages 1681-1687.
Read now
Read now
M Reza Razeghinejad, Andrea K Sawchyn & L Jay Katz. (2010) Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma. Expert Opinion on Pharmacotherapy 11:6, pages 959-968.
Read now
Read now
Louis B. Cantor, Ching-Chi Liu, Amy L. Batoosingh & David A. Hollander. (2009) Safety and tolerability of brimonidine purite 0.1% and brimonidine purite 0.15%: a meta-analysis of two phase 3 studies. Current Medical Research and Opinion 25:7, pages 1615-1620.
Read now
Read now